March Biosciences (March Bio), a clinical stage biotechnology company developing cell therapies for hard-to-treat cancers, today announced that the U.S. Food and Drug Administration (FDA) has granted ...

Q3 2025 Earnings Call Transcript November 4, 2025 Taysha Gene Therapies, Inc. misses on earnings expectations. Reported EPS ...

Announced pivotal topline data from Phase I/II study of AMT-130 in Huntington’s disease met its primary and key secondary endpoints, ...

Excerpts from recent editorials in the United States and abroad: ___ Nov. 9 The Washington Post says TrumpRx isn't the best way to lower prices In a landmark deal announced Thursday, President Donald ...

Detailed price information for Precision Biosciences Inc (DTIL-Q) from The Globe and Mail including charting and trades.

James Watson, the Nobel Prize-winning scientist who co-discovered DNA’s double-helix structure and later faced backlash for ...

The bladder cancer treatment landscape is rapidly evolving, particularly for patients who don’t respond to bacillus ...

Is Religion Still Relevant? Leaders from four major religions gathered for interfaith dialogue at one of Britain’s most ...

Stifel 2025 Healthcare Conference November 11, 2025 9:20 AM ESTCompany ParticipantsKim Kelderman - CEO, President ...

CAR T and CAR Treg therapies revolutionize cancer treatment through automation, scalability, and global manufacturing innovation.

An analysis has found that the popularization of advanced regenerative medicine, made possible by a legal amendment in February, is highly likely to ...

The KEYMAKER-U03 trial showed a triplet regimen of belzutifan, pembrolizumab, and lenvatinib significantly improved ...